Epigenetics is the study of how external factors, such as diet, environment and lifestyle, can alter gene expression without changing the underlying genetic code. Epigenetic pathways refer to the range of mechanisms that underlie these modifications and control the expression of genes. Epigenetic pathways are regulated by small chemical tags called epigenetic marks that are added to the DNA. These cues tell the cell which genes should be expressed and which should remain inactive. Epigenetic marks can be added or removed to control gene expression and to influence the developmental processes of the cell. Epigenetic marks can either silence genes or activate them. The best studied form of epigenetic silencing is DNA methylation, in which molecules called methyl groups are attached to DNA. These methyl groups block gene activity, by interfering with the proteins that bind to the gene and control its expression. On the other hand, acetylation of histones – proteins that package and organize DNA – can promote gene expression. When acetyl groups are added to histones, they can interact with the DNA and help activate the gene. Complex interactions between epigenetic marks, proteins, and other molecules in the cell create a unique set of configurations that determine how genes are expressed. Researchers are using cutting-edge technologies to understand how these pathways interact and how they can influence gene expression and development. Ultimately, epigenetic pathways play a critical role in many biological processes, such as ageing, cell differentiation, and disease. By understanding how epigenetic pathways work, scientists are unlocking vital information that can be used to develop treatments for diseases and improve human health.
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : The role of beliefs, perception, and behavioural patterns in the evolution of psychophysical disorders
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : A multiscale systems biology framework integrating ODE-based kinetics and MD-derived structural affinities to model mBDNF–proBDNF-mediated bifurcation dynamics in CNS neurotrophin signaling
Krishna Moorjani, Boston University, United States
Title : A multiscale systems biology framework integrating ODE-based kinetics and MD-derived structural affinities to model mBDNF–proBDNF-mediated bifurcation dynamics in CNS neurotrophin signaling
Abhay Murthy, Boston University, United States
Title : A multiscale systems biology framework integrating ODE-based kinetics and MD-derived structural affinities to model mBDNF–proBDNF-mediated bifurcation dynamics in CNS neurotrophin signalling
Ethan Liu, Boston University, United States